Acrivon Therapeutics, Inc.·4

Feb 19, 5:00 PM ET

Peterson Katharine 4

4 · Acrivon Therapeutics, Inc. · Filed Feb 19, 2025

Insider Transaction Report

Form 4
Period: 2025-02-14
Peterson Katharine
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2025-02-14$5.42/sh116$6294,419 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file
  • 4
    form4.xmlPrimary